SinuSys Expands Executive Team

Published: Mar 18, 2013

SinuSys Corporation, an innovative sinus health company, today announced recent additions to its management team as it expands its global commercialization activities for the SinuSys Dilation System and continues its progress toward FDA 510(k) clearance. The Company has appointed Michael Daniel as acting Vice President, Regulatory; Eric Schaefer as Director, Commercial Development; and Sagar Pushpala as Operations Advisor.

Back to news